News Headlines Article

New prescription drugs can help patients, but their high prices elicit ire
Los Angeles Times

They sounded like three deadly strikes.

The patient had a dangerously high level of LDL cholesterol, a high risk for heart disease and an intolerance for the most common cholesterol-fighting medication.

Dr. William Averill, a Torrance cardiologist, thought he had a solution: Praluent, a cholesterol-lowering drug from pharmaceutical companies Regeneron and Sanofi that had just been approved by the FDA as a treatment for people who didn’t benefit from the standard cholesterol treatment.